Toth Financial Advisory Corp Purchases 4,846 Shares of CVS Health Co. (NYSE:CVS)

Toth Financial Advisory Corp increased its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 15.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 37,149 shares of the pharmacy operator's stock after buying an additional 4,846 shares during the quarter. Toth Financial Advisory Corp's holdings in CVS Health were worth $2,517,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Stonebridge Financial Group LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC lifted its position in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares during the last quarter. Financial Perspectives Inc lifted its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. lifted its position in shares of CVS Health by 112.1% in the fourth quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after buying an additional 437 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently issued reports on CVS. Robert W. Baird raised their price objective on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Finally, Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Buying and Selling

In other news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

Shares of CVS Health stock traded up $0.62 during trading on Thursday, reaching $66.34. 6,562,248 shares of the company's stock were exchanged, compared to its average volume of 11,006,344. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a market cap of $83.92 billion, a P/E ratio of 18.13, a PEG ratio of 0.98 and a beta of 0.56. The firm's 50-day moving average price is $65.11 and its 200 day moving average price is $60.05.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter in the previous year, the firm earned $1.31 EPS. CVS Health's revenue was up 7.0% on a year-over-year basis. As a group, research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. CVS Health's dividend payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.